A Cross-sectional Study to Assess the Effectiveness and Safety of Ofatumumab (Kesimpta®) in Patients With Relapsing Multiple Sclerosis in the Spanish Clinical Practice

Novartis Investigative Site, Cáceres

Novartis Investigative Site, Córdoba

Novartis Investigative Site, Santiago de Compostela

Novartis Investigative Site, Salt

Novartis Investigative Site, Granada

Novartis Investigative Site, León

Novartis Investigative Site, Logroño

Novartis Investigative Site, Madrid

Novartis Investigative Site, Madrid

Novartis Investigative Site, Madrid

Novartis Investigative Site, Madrid

Novartis Investigative Site, Madrid

Novartis Investigative Site, Madrid

Novartis Investigative Site, Fuenlabrada

Novartis Investigative Site, Málaga

Novartis Investigative Site, Pamplona

Novartis Investigative Site, Vigo

Novartis Investigative Site, Santa Cruz de Tenerife

Novartis Investigative Site, Santander

Novartis Investigative Site, Seville

Novartis Investigative Site, Seville

Novartis Investigative Site, Valencia

Novartis Investigative Site, Valencia

Novartis Investigative Site, Barakaldo

Novartis Investigative Site, Zamora

Novartis Investigative Site, Zaragoza

Novartis Investigative Site, Palma de Mallorca

Novartis Investigative Site, L'Hospitalet de Llobregat

Novartis Investigative Site, Albacete

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Alicante

Novartis Investigative Site, Burgos